We read every piece of feedback, and take your input very seriously.
To see all available qualifiers, see our documentation.
Learn more about SEND from CDISC
Create SEND database with sendigR
FDA Guidance - Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers
ICH - GUIDANCE ON NONCLINICAL SAFETY STUDIES FOR THE CONDUCT OF HUMAN CLINICAL TRIALS AND MARKETING AUTHORIZATION FOR PHARMACEUTICAL M3(R2)
FDA - M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
Making sense of SEND; the Standard for Exchange of Nonclinical Data
The Standard for the Exchange of Nonclinical Data (SEND): Challenges and Promises
Leveraging the Value of CDISC SEND Data Sets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals
SEND harmonization & cross-study analysis: A proposal to better harvest the value from SEND data